Miss Isabella Revesz
Higher Degree by Research Candidate
School of Medicine
College of Health
Isabella Révész is completing her PhD in the Centre for Pharmaceutical Innovation as part of the Nanostructure and Drug Delivery Group, having previously completed a Bachelor of Medical Science and a Bachelor of Biomedical Research (Honours). Isabella’s current research is focused on the development of novel lipid-based nanocarriers for effective cancer immunotherapies.
| Year | Citation |
|---|---|
| 2025 | Habib, A., Mynott, R. L., Best, O. G., Revesz, I. A., Prestidge, C. A., & Wallington-Gates, C. T. (2025). Novel (1S,3R)-RSL3-Encapsulated Polyunsaturated Fatty Acid Rich Liposomes Sensitise Multiple Myeloma Cells to Ferroptosis-Mediated Cell Death. International Journal of Molecular Sciences, 26(14), 23 pages. Scopus1 WoS1 Europe PMC1 |
| 2024 | Revesz, I. A., Joyce, P., Ebert, L. M., & Prestidge, C. A. (2024). Effective γδ T-cell clinical therapies: current limitations and future perspectives for cancer immunotherapy. Clinical and Translational Immunology, 13(2, article no. e1492), 1-16. Scopus9 WoS9 Europe PMC7 |
| 2022 | Revesz, I. A., Hickey, S. M., & Sweetman, M. J. (2022). Metal ion sensing with graphene quantum dots: detection of harmful contaminants and biorelevant species. Journal of Materials Chemistry B, 10(23), 4346-4362. Scopus37 WoS34 Europe PMC12 |
Courses I teach
- BIOL 1007 Biology A (2024)
- CHEM 2028 Synthetic Chemistry (2024)
- PHAR 2014 Dosage Form Design 1 (2024)
Connect With Me
External Profiles
